Response to bortezomib of a patient with scleromyxedema refractory to other therapies

Magdalini Migkou; Μαρία Γκοτζαμανίδου; Evangelos Terpos; Meletios A Dimopoulos; Efstathios Kastritis

doi:10.1016/j.leukres.2011.07.021

Related publications

Article2005

Treatment of relapsed or refractory Waldenström's macroglobulinemia with bortezomib.

Meletios A Dimopoulos, Athanasios K. Anagnostopoulos, Maria Christina Kyrtsonis, Efstathios Castritis, Athanasios Bitsaktsis, Gerassimos A. Pangalis

Article2016

Cases with Refractory Ascites and a Delayed Response to Tolvaptan

Satoru Hagiwara, Naoshi Nishida, Hirokazu Chishina, Hiroshi Ida, Toshiharu Sakurai, Yoriaki Komeda, Masayuki Kitano, Masatoshi Kudo

Article2008

Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib

Konstantinos Anargyrou, Evangelos Terpos, T. P. Vassilakopoulos, Anastasia Pouli, Sotirios Sachanas, Τατιάνα Τζένου, Stavroula Masouridis, D. Christoulas, Maria K. Angelopoulou, Evangelia M. Dimitriadou, Christina Kalpadakis, Konstantinos Tsionos, Panayiotis Panayiotidis, Meletios A Dimopoulos, Gerassimos A. Pangalis, Maria‐Christina Kyrtsonis

Article2021

Correction to: Refractory anti‑NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review

Serena Marita Lazzarin, Marco Vabanesi, Giordano Cecchetti, Raffaella Fazio, Giovanna Franca Fanelli, Maria Antonietta Volonté, Angela Genchi, Antonino Giordano, Vittorio Martinelli, Sergio Colombo, Paolo Beccaria, Milena Mucci, Jacopo Peccatori, Massimo Filippi, Fabio Minicucci

Article2025

Dialysis independence for a young patient with refractory multiple myeloma treated with teclistamab: A case report

Ioannis Ntanasis‐Stathopoulos, Ilias Katsadouros, Panagiotis Malandrakis, Erasmia Psimenou, Meletios A Dimopoulos, Maria Gavriatopoulou